Should a pterygium be referred to an ophthalmologist (ophtho)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, a pterygium should be referred to an ophthalmologist for evaluation and management. A pterygium is a benign growth of conjunctival tissue that extends onto the cornea, typically on the nasal side. While not all pterygia require immediate treatment, an ophthalmologist should assess the condition to determine its severity and appropriate management. Referral is particularly important if the pterygium is growing rapidly, causing discomfort, affecting vision, or cosmetically concerning to the patient. The ophthalmologist may recommend conservative management with lubricating eye drops, preservative-free artificial tears, or mild steroid drops for inflammation. For more advanced cases causing visual disturbance or significant discomfort, surgical removal may be necessary. Surgery is the only definitive treatment for pterygium, but recurrence is possible. Early evaluation is beneficial as the ophthalmologist can monitor progression over time and intervene before the pterygium encroaches on the visual axis. Additionally, the specialist can rule out other ocular surface conditions that might mimic pterygium appearance.

Key Considerations

  • The ophthalmologist should discuss and explain the findings and discuss management options with the patient, as indicated by 1.
  • Referral to an ophthalmologist is crucial for determining the severity of the pterygium and appropriate management, especially if the condition is causing visual disturbance or significant discomfort.
  • The ophthalmologist can provide education on the condition, its management, and the potential risks and benefits of treatment, as emphasized in 1 and 1.
  • Early evaluation and management can improve outcomes and reduce the risk of complications, such as visual impairment or recurrence of the pterygium.

Management Options

  • Conservative management with lubricating eye drops, preservative-free artificial tears, or mild steroid drops for inflammation may be recommended for mild cases.
  • Surgical removal may be necessary for more advanced cases causing visual disturbance or significant discomfort.
  • The ophthalmologist can monitor progression over time and intervene before the pterygium encroaches on the visual axis, as suggested by 1.

From the Research

Pterygium Referral to Ophthalmologist

  • A pterygium is a bulbar conjunctival fibrovascular growth that can lead to significant visual complications, including eye irritation, corneal astigmatism, and damage to the visual axis leading to vision impairment 2.
  • The treatment of pterygium has been developed, and various new solutions have been used, with surgery being the main treatment 2, 3, 4.
  • Surgical techniques such as conjunctival autograft, amniotic membrane graft, and bare sclera excision are used to remove the pterygium, with conjunctival autograft being associated with a lower risk of recurrence at six months after surgery compared to amniotic membrane transplant 5.
  • Adjunctive therapies such as mitomycin C, beta-irradiation, and interferons are also used to reduce recurrence rates, but their use should be judicious due to the potential long-term risk of sight-threatening complications 3, 6.
  • Given the potential for significant visual complications and the various treatment options available, it is recommended that a pterygium be referred to an ophthalmologist for evaluation and treatment 2, 3, 4, 5, 6.

Key Considerations

  • The risk of recurrence is a dominant complication of pterygium excision, regardless of the adopted surgical procedure 4.
  • Conjunctival autografting and mitomycin C application are the most commonly used methods for preventing recurrences 6.
  • The use of adjunctive therapies should be carefully considered due to the potential long-term risks of sight-threatening complications 3, 6.
  • Further research is needed to evaluate the relative efficacies and long-term safety of the various treatment modalities 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Update on overview of pterygium and its surgical management.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022

Research

[Pterygium: etiology, pathogenesis, treatment].

Vestnik oftalmologii, 2017

Research

Pterygium: A review of clinical features and surgical treatment.

Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria, 2011

Research

Conjunctival autograft for pterygium.

The Cochrane database of systematic reviews, 2016

Research

Current concepts and techniques in pterygium treatment.

Current opinion in ophthalmology, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.